N. Xu

LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells

Xin-Jiang Lu, Jiong Chen, Qiang Chen, 2016, Nature Communications.

Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy

A. Dolnikov, N. Xu, Tiffany C. Y. Tang, 2020 .

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

P. Gregory, M. Holmes, Kamola Saydaminova, 2015, Molecular therapy. Methods & clinical development.

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.

A. Dolnikov, T. O'Brien, S. Joshi, 2015, Experimental hematology.

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

A. Dolnikov, M. Haber, K. Micklethwaite, 2021, ImmunoTargets and therapy.

Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer

A. Dolnikov, T. O'Brien, N. Xu, 2014 .

Characterizing piggyBat—a transposase for genetic modification of T cells

B. Gloss, A. Dolnikov, K. Gowrishankar, 2022, Molecular therapy. Methods & clinical development.